- Definition, Types & Side Effects Langerhans Cell Histiocytosis: Prognosis, Treatment & Symptoms Malignant Neoplasm | Overview & Examples Testicular Cancer: Symptoms, Treatment & Causes Molecular Testing & Diagnostics for Solid Tumors Role of Lipids in the Development of Cancer Esophageal Cancer: ...
DefinitionThe distinction between benign and malignant tumors is classically based on the metastatic potential of a tumor type. While desmoid tumors do not metastasize and as such are classified as benign lesions, their clinical behavior, cellular biology, and molecular etiology all share more ...
Biology and therapy of malignant solid tumors in childhood No Abstract dBH Van - 《Cancer Chemotherapy & Biological Response Modifiers Annual》 被引量: 0发表: 2005年 Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors Isolation and growth ...
Experimental design:We evaluated the expression of PIAS3 inmesothelioma tumors from patients and correlated the expression levels with the course of the disease. We also measured the effects of enhanced PIAS3 activity on STAT3 signaling, cellular growth, and viability in cultured mesothelioma cells. ...
c Strongly and commonly expressed interacting genes in tumors (left) or TAMs (right). The genes with average expression over quantile 0.95 and a fraction of expressing cells over 0.75 were labeled. d Top 10 abundant interaction pairs (>10,224 pairs in each interaction) related to c...
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 1997;3:177–82. Article CAS PubMed Google Scholar Peng G, Wang Y, Ge P, Bailey C, Zhang P, Zhang D, et al. The HIF1α-PDGFD-PDGFRα axis controls ...
Generally considered indolent, ovarian tumors of low malignant potential (LMP) have a small but finite risk of aggressive behavior. There is controversy surrounding the management of both the indolent and aggressive variants of ovarian LMP tumors. This review will explore the recent advances in the ...
(1979). New Primary Malignant Tumors in Patients Treated for Carcinoma of the Uterine Cervix or Corpus. Acta Radiologica: Oncology, Radiation, Physics, Biology: Vol. 18, No. 1, pp. 25-30.
Bromodomain-containing protein 9 (BRD9) is a recently identified subunit of SWI/SNF(BAF) chromatin remodeling complexes, yet its function is poorly understood. Here, using a genome-wide CRISPR-Cas9 screen, we show that BRD9 is a specific vulnerability in pediatric malignant rhabdoid tumors (RTs...
4. Benign and malignant lung tumors could be distinguished with high accuracy. 5. The findings of previous studies35,36 that indicated that SHP is sensitive to the microenvironment of a tumor were confirmed. These findings also confirm similar results from SCP, an equivalent spectral method ...